Clinical significance and changes of serum visfatin, adiponectin and leptin levels in patients with polycystic ovarian syndrome

Journal of Central South University (Medical Sciences)

Volumn 34, Issue 1, 2009, Pages 72-75

  Wang, Yongjun ^a   Yu, Ping ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Central South University   (China)

Author keywords

Adiponectin; Insulin resistance; Leptin; Polycystic ovary syndrome; Visfatin

Indexed keywords

ADIPONECTIN; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CASE CONTROL STUDY; FEMALE; HUMAN; INSULIN RESISTANCE; OVARY POLYCYSTIC DISEASE; PHYSIOLOGY;

ADIPONECTIN; ADOLESCENT; ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; POLYCYSTIC OVARY SYNDROME; YOUNG ADULT;

EID: 60149107163     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Battaglia C, Mancini F, Cianciosi A, et al. Vascular risk in young women with polycystic ovary and polycystic ovary syndrome [J]. Obstet Gynecol, 2008, 111(2):385-395.
2. Shanik M H, Xu Y, Skrha J, et al. Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse? [J]. Diabetes Care, 2008, 31 (Suppl 2):S262-268.
3. Panidis D, Farmakiotis D, Rousso D, et al. Plasma visfatin levels in normal weight women with polycystic ovary syndrome [J]. Eur J Intern Med, 2008, 19(6):406-412.
4. YU Qi. Understanding on the criteria of diagnostic and treatment of polycystic ovary syndrome [J]. Chinese Journal of Practical Gynecology and Obstetrics, 2007, 23(6):474.
5. Valle F, Azziz R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus [J]. Fertil Steril, 2002, 77(6):1095-1105.
6. WANG Xingjuan, WANG Jing, JIA Lina, et al. Observation of the serum leptin in 81 patients with polycystic ovarian syndrome [J]. Journal of Fudan University. Medical Sciences, 2007, 34(4):537-540.
7. Zahorska-Markiewicz B, Olszanecka-Glinianowicz M, Janowska J, et al. Serum concentration of visfatin in obese women [J]. Metabolism, 2007, 56(8):1131-1134.
8. Sethi J K, Vidai-Puig A. Visfatin:the missing link between intraabdominal obesity and diabetes? [J]. Trends Mol Med, 2005, 11(8):344-347.
9. Chen M P, Chung F M, Chang DM, et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with Type 2 diabetes mellitus [J]. J Clin Endocrinol Metab, 2006, 91(1):295-299.
10. Berndt J, Kloting N, Kralishch S, et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans [J]. Diabetes, 2005, 54(10):2911-2916.
11. LIU Fang, WANG Xin, LU Junxi, et al. Visfatin and adiponectin levels in metabolic syndrome patients and their influencing factors [J]. Journal of Fudan University. Medical Sciences, 2007, 34(2):239-242.
12. Chan T F, Chen Y L, Chen HH, et al. Increased plasma visfatin concentrations in women with polycystic ovary syndrome [J]. Fertil Steril, 2007, 88(2):401-405.
13. JIANG Fengxiu, BI Yaxin. Research on visfatin [J]. Anatomy and Clinics, 2008, 13(1):63-64.